Clinical Trial

Study on the Effectiveness and Mechanism of Tong-Xie-Yao-Fang in Treating Diarrhea-predominant Irritable Bowel Syndrome

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated December 17, 2024 (before its estimated October 8, 2025 completion). Its status may not reflect the trial's current state.
Summary
Traditional Chinese Medicine focuses on the main pathogenesis of liver depression and spleen deficiency, and treats them from the perspective of soothing the liver and strengthening the spleen to treat on Diarrhea-predominant irritable bowel syndrome (IBS-D) . The classic formula for treating is the Tong-Xie-Yao-Fang (TXYF). Based on metabolomics and metagenomics, the research group studied the intestinal flora and host co metabolism of TXYF in the treatment of diarrhea predominant IBS-D, in order to clarify the mechanism of TXYF in the treatment of IBS-D.
Trial Details
NCT Number NCT06737666
Lead Sponsor Xiyuan Hospital of China Academy of Chinese Medical Sciences
Conditions Diarrhea-predominant Irritable Bowel Syndrome
Enrollment 60 participants
Start Date 2023-05-29
Primary Completion 2025-10-08 (estimated)
Study Completion 2025-12 (estimated)
Updated on ClinicalTrials.gov 2024-12-17